Skip to content

Clinical trials

Alzheimer Disease trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Belgium Clear all

97 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20062
20072
20084
20093
20102
20112
20122
20138
201411
20158
20167
20178
20184
20193
20206
20214
20224
20231
20247
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Terminated28
Recruiting10
Unknown status9
Active, not recruiting2
Not yet recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC13
Universitaire Ziekenhuizen KU Leuven9
Pfizer8
Hoffmann-La Roche7
Novartis Pharmaceuticals4
AstraZeneca3
Biogen3
TauRx Therapeutics Ltd3
Universitair Ziekenhuis Brussel3
AbbVie2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease97
Dementia22
Cognitive Dysfunction13
Neurodegenerative Diseases8
Brain Diseases7
Amyloid Neuropathies, Familial5
Lewy Body Disease5
Amyloidosis4
Cardiomyopathies4
Central Nervous System Diseases3

Trials

Showing 76 to 97 of 97. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.